Which has grown faster, CAH or MRNA?

Over the past five years, MRNA grew revenue faster — CAH at a 9.37% CAGR versus MRNA at 19.33%.

Does CAH or MRNA pay a bigger dividend?

CAH pays a dividend (0.87% yield), while MRNA has no payments in the available dividend history.

Is CAH or MRNA more profitable?

CAH runs the higher net margin — CAH at 0.67% versus MRNA at -141.43%.

How have CAH and MRNA total returns compared?

Over the past 5 years, CAH delivered 14.27% and MRNA delivered -14.22% annualized total return. Past performance doesn't predict future results.

Cardinal Health, Inc. (CAH) vs Moderna, Inc. (MRNA)

A side-by-side comparison of Cardinal Health, Inc. and Moderna, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 20, 2026. Differences are shown without an overall score or investment verdict.

CAH

Cardinal Health, Inc.

$55.00B

$234.85HealthcareDelayed quote: Aug 19, 2026, 4:00 PM EDT

MRNA

Moderna, Inc.

$69.19B

$174.38HealthcareAt close: Aug 19, 2026, 4:00 PM ET

Total return — CAH vs MRNA

growth of $100 · dividends reinvested · last 8y

CAH +430.4% (+23.2%/yr)MRNA +837.5% (+32.3%/yr)MRNA compounded faster over this window

CAH MRNA

CAH vs MRNA: by the numbers

•MRNA is the larger company ($69.19B vs $55.00B market cap).
•CAH is profitable (0.67% net margin) while MRNA runs a net loss (-141.43%).
•MRNA grew revenue faster over the past five years (19.33% vs 9.37% CAGR).
•CAH pays a dividend (0.87% yield), while MRNA has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	CAH	MRNA
P/E ratio	32.48	N/A
Forward P/E	21.79	N/A
P/S ratio	0.22	30.99
P/B ratio	N/A	10.21
EV / EBITDA	17.02	N/A
FCF yield	8.13%	N/A

Profitability

Metric	CAH	MRNA
Gross margin	3.84%	55.35%
Operating margin	1.03%	-158.13%
Net margin	0.67%	-141.43%
ROE	-59.45%	-46.61%
ROIC	13.45%	-39.16%

Dividends

Metric	CAH	MRNA
Dividend yield	0.87%	N/A
Payout ratio	28.17%	N/A

Growth (annualized)

Metric	CAH	MRNA
Revenue CAGR (5Y)	9.37%	19.33%
EPS CAGR (5Y)	28.32%	N/A
FCF CAGR (5Y)	17.40%	N/A
Total return CAGR (5Y)	38.55%	-14.22%

Frequently asked

Which has grown faster, CAH or MRNA?: Over the past five years, MRNA grew revenue faster — CAH at a 9.37% CAGR versus MRNA at 19.33%.
Does CAH or MRNA pay a bigger dividend?: CAH pays a dividend (0.87% yield), while MRNA has no payments in the available dividend history.
Is CAH or MRNA more profitable?: CAH runs the higher net margin — CAH at 0.67% versus MRNA at -141.43%.
How have CAH and MRNA total returns compared?: Over the past 5 years, CAH delivered 14.27% and MRNA delivered -14.22% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CAH analysis Full MRNA analysis Interactive comparison tool

Dig into the metrics

Cardinal Health P/E ratio Cardinal Health dividend yield Cardinal Health ROE Moderna ROE Cardinal Health operating margin Moderna operating margin Cardinal Health revenue growth Moderna revenue growth Cardinal Health free cash flow Moderna free cash flow

Cardinal Health & Moderna appear in these rankings

25+ Year Dividend Growers Fastest Revenue Growth Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 20, 2026.